Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
blue shield of california glp 1 MCT2D Glucagon-Like Peptide-1 (GLP-1) Agonists: status:live-noHCC-noGC Purchase Plan:1-Month Supply
Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing Waistlines, Increasing Poison Center Cases
Tier 1: Pure GLP-1, injectable, FDA-approved Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) Dulaglutide (Trulicity) Semaglutide (Ozempic, Wegovy) Efpeglenatide (Eperzan) Tier 2: Pure GLP-1, oral, FDA-approved Semaglutide (Rybelsus) Orforglipron (Orfoglip) Tier 3: Dual or triple agonist, FDA-approved Tirzepatide (Mounjaro, Zepbound) Retatrutide (Retara) Tier 4: Compounded (not FDA-approved) Compounded semaglutide Compounded tirzepatide Compounded semaglutide + B12 Compounded tirzepatide + B12 The tier system reflects regulatory status, not efficacy
status:live-noHCC-noGC
Purchase Plan:1-Month Supply
While the recent launches of GLP-1 drugs from Novo Nordisk and Eli Lilly have been nothing short of a staggering financial success, the rollouts have consistently been hamstrung by manufacturing and supply constraints
US$ 26.78
US$ 27.40
US$ 25.65
US$ 29.71
